Società Freeline Therapeutics Holdings plc
Azioni
FRLN
US35655L2060
Biotecnologia
Attività
Numero di dipendenti: 152
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Markus Hörer
FOU | Founder | - | 01/01/15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 15/03/21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 16/05/22 |
Chief Tech/Sci/R&D Officer | 57 | 01/03/22 | |
Pamela Foulds
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/11/21 |
James Bircher
COO | Chief Operating Officer | 56 | 01/07/21 |
Naomi Aoki
IRC | Investor Relations Contact | - | - |
Chip McCorkle
LAW | General Counsel | - | - |
Nicole Jones
HRO | Human Resources Officer | 54 | 11/07/22 |
Amy J. Spandau
PRN | Corporate Officer/Principal | - | 01/02/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chris Hollowood
CHM | Chairman | 50 | 01/12/15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 15/03/21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 16/05/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 65 369 417 | 64 715 513 ( 99,00 %) | 0 | 99,00 % |
Coordinate società
Freeline Therapeutics Holdings Plc
Sycamore House Gunnels Wood Road
SG1 2BP, Stevenage
+44 14 3890 6870
http://www.freeline.life![Indirizzo Freeline Therapeutics Holdings plc(FRLN)](https://cdn.zonebourse.com/static/address/110594703.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+16,49% | 122 Mrd | |
+21,73% | 115 Mrd | |
+22,30% | 26,64 Mrd | |
-21,81% | 19,91 Mrd | |
-17,01% | 16,32 Mrd | |
-18,81% | 15,49 Mrd | |
-44,74% | 15,52 Mrd | |
+62,72% | 14,83 Mrd | |
+3,09% | 13,67 Mrd |